+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atopic Dermatitis Drugs Market by Drug Class (Systemic, Topical), Route Of Administration (Cream, Gel, Lotion), Mode Of Administration, Distribution Channel, Patient Age Group - Global Forecast 2025-2030- Product Image
Atopic Dermatitis Drugs Market by Drug Class (Systemic, Topical), Route Of Administration (Cream, Gel, Lotion), Mode Of Administration, Distribution Channel, Patient Age Group - Global Forecast 2025-2030- Product Image
Sale

Atopic Dermatitis Drugs Market by Drug Class (Systemic, Topical), Route Of Administration (Cream, Gel, Lotion), Mode Of Administration, Distribution Channel, Patient Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904629
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The atopic dermatitis drugs market is advancing rapidly as therapeutic innovations, enhanced patient engagement strategies, and evolving care models fuel new standards for treatment and commercial growth. Senior decision-makers seeking to harness both technology and operational efficiency to address rising prevalence and treatment complexity will find critical insights in this comprehensive analysis.

Market Snapshot: Atopic Dermatitis Drugs Market Growth and Outlook

The Atopic Dermatitis Drugs Market grew from USD 8.56 billion in 2024 to USD 9.18 billion in 2025. It is expected to continue growing at a CAGR of 6.87%, reaching USD 12.77 billion by 2030. Global demand is driven by rising incidence across regions, swift therapeutic advances, and heightened awareness among healthcare providers and patients. This outlook positions the sector for robust expansion, offering attractive prospects for investment and strategic positioning.

Scope & Segmentation of the Atopic Dermatitis Drugs Market

This report delivers in-depth analysis and forecasts across a detailed range of product classes, administration formats, sales channels, and end-user demographics to support decision-making at both operational and portfolio levels. Market coverage includes a granular view of regional dynamics and an evaluation of innovations shaping patient access and competitive profiles.

  • Drug Class: Biologics, Small Molecule Immunosuppressants, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors, Vitamin D Analogues
  • Route of Administration: Cream, Gel, Lotion, Ointment
  • Mode of Administration: Injectable (Pre-filled Syringes, Vials), Oral
  • Distribution Channel: Hospital Pharmacies (Private, Public), Online Pharmacies (Digital Health Platforms, E-commerce Platforms), Retail Pharmacies (Chain, Independent)
  • Patient Age Group: Adult, Geriatric, Pediatric
  • Key Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Notable Companies: Regeneron Pharmaceuticals, Inc.; Sanofi; Pfizer Inc.; AbbVie Inc.; Eli Lilly and Company; Johnson & Johnson; LEO Pharma A/S; Galderma S.A.; Teva Pharmaceutical Industries Ltd.; Viatris Inc.

Key Takeaways for Senior Decision-Makers

  • Targeted biologics and new-generation small molecule therapies are transforming treatment paradigms, unlocking more precise interventions and improved patient outcomes.
  • Digital health platforms and AI-enabled diagnostics are streamlining access, enabling teledermatology, and boosting adherence in both mature and emerging markets.
  • Segmented offerings by drug class, administration route, and distribution channel allow for more effective alignment with shifting demographic and clinical needs.
  • Regional differences in regulatory processes, reimbursement schemes, and healthcare infrastructure inform market entry strategies and operational models.
  • Strategic alliances with biotech firms, academic centers, and supply partners are helping industry leaders rapidly translate research advances into commercial opportunities and differentiated therapies.

Tariff Impact: Navigating US Policy Shifts in Pharmaceutical Supply Chains

Recent tariff adjustments in the United States directly affect supply chains for atopic dermatitis pharmaceuticals, impacting both biologic and generic compounds. Manufacturers are pursuing cost mitigation through strategic procurement, nearshoring, and inventory optimization. Payers and providers are anticipating adaptation needs, including formulary management and collaborative alliances, to ensure patient access and cost-effectiveness amid evolving regulatory landscapes.

Methodology & Data Sources

This report utilizes a combination of primary interviews with dermatology specialists, opinion leaders, and pharmaceutical executives, as well as surveys across major markets. Secondary research draws on peer-reviewed literature, industry white papers, and patent filings. Data triangulation, expert validation, and rigorous quality-control measures ensure accuracy and actionable insight.

Atopic Dermatitis Drugs Market: Why This Report Matters

  • Provides a strategic framework to identify emerging therapeutic opportunities and optimize operational performance.
  • Equips decision-makers with robust benchmarks for investment, portfolio development, and competitive risk assessment.
  • Supports scenario planning, regulatory navigation, and patient-centric engagement through thorough segmentation and region-by-region analysis.

Conclusion

The atopic dermatitis drugs market is on a path of sustained evolution driven by clinical innovation, digital transformation, and adaptive supply chains. This analysis empowers leadership teams to anticipate market shifts and strengthen their competitive posture for lasting impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of JAK inhibitors redefining moderate-to-severe atopic dermatitis treatment protocols
5.2. Advancement in topical microbiome-based therapies reducing relapse rates in atopic dermatitis patients
5.3. Expansion of biologic therapies pipeline targeting novel interleukin pathways for atopic dermatitis
5.4. Personalized treatment regimens leveraging genetic biomarkers to predict atopic dermatitis drug response
5.5. Rising off-label use and reimbursement challenges for emerging atopic dermatitis therapies
5.6. Integration of teledermatology and digital monitoring platforms in atopic dermatitis management
5.7. Strategic partnerships between pharmaceutical and biotech firms accelerating atopic dermatitis drug development
5.8. Growing focus on patient-reported outcomes and quality-of-life metrics in atopic dermatitis clinical trials
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Atopic Dermatitis Drugs Market, by Drug Class
8.1. Introduction
8.2. Systemic
8.2.1. Biologics
8.2.2. Small Molecule Immunosuppressants
8.3. Topical
8.3.1. Calcineurin Inhibitors
8.3.2. Corticosteroids
8.3.3. PDE4 Inhibitors
8.3.4. Vitamin D Analogues
9. Atopic Dermatitis Drugs Market, by Route Of Administration
9.1. Introduction
9.2. Cream
9.3. Gel
9.4. Lotion
9.5. Ointment
10. Atopic Dermatitis Drugs Market, by Mode Of Administration
10.1. Introduction
10.2. Injectable
10.2.1. Pre Filled Syringes
10.2.2. Vials
10.3. Oral
11. Atopic Dermatitis Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. Private Hospital Pharmacies
11.2.2. Public Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. Digital Health Platforms
11.3.2. E Commerce Platforms
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Atopic Dermatitis Drugs Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Atopic Dermatitis Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Atopic Dermatitis Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Atopic Dermatitis Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Regeneron Pharmaceuticals, Inc.
16.3.2. Sanofi
16.3.3. Pfizer Inc.
16.3.4. AbbVie Inc.
16.3.5. Eli Lilly and Company
16.3.6. Johnson & Johnson
16.3.7. LEO Pharma A/S
16.3.8. Galderma S.A.
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ATOPIC DERMATITIS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ATOPIC DERMATITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ATOPIC DERMATITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ATOPIC DERMATITIS DRUGS MARKET: RESEARCHAI
FIGURE 26. ATOPIC DERMATITIS DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. ATOPIC DERMATITIS DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. ATOPIC DERMATITIS DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ATOPIC DERMATITIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SMALL MOLECULE IMMUNOSUPPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SMALL MOLECULE IMMUNOSUPPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VITAMIN D ANALOGUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VITAMIN D ANALOGUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY LOTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY LOTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRE FILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRE FILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DIGITAL HEALTH PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DIGITAL HEALTH PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 135. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 136. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 137. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 138. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 139. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 140. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 141. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 146. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 147. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 150. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 151. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 152. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 153. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 154. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 155. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 156. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 269. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 270. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 271. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 272. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 273. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 274. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 287. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 288. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 289. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 290. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 291. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 292. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 294. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 295. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 296. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 297. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 302. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 303. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 306. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 307. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 308. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 309. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 310. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 311. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 312. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA ATOPIC DERMAT

Samples

Loading
LOADING...

Companies Mentioned

  • Regeneron Pharmaceuticals, Inc.
  • Sanofi
  • Pfizer Inc.
  • AbbVie Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • LEO Pharma A/S
  • Galderma S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.77 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Atopic Dermatitis Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Atopic Dermatitis Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Atopic Dermatitis Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Atopic Dermatitis Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 120 Pages
  • Global
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.